Category: Governance risk · Reviewed by Amy Price, Account Executive · Last reviewed 2026-06-10
Corporate governance insurance is the suite of UK insurance products — principally directors’ and officers’ (D&O) liability, entity securities cover and bespoke governance endorsements — that responds to claims and investigations arising from alleged failures of board oversight, governance process or disclosure under the UK Corporate Governance Code, the Companies Act 2006 and the FCA Handbook.
Category: Governance risk Also known as: governance liability cover, board liability insurance, corporate governance D&O Typical UK market form: D&O Side A/B/C primary and excess layers, often with bespoke governance-failure and pre-claim inquiry sub-limits Related concepts: Directors and officers insurance, UK Corporate Governance Code, ESG governance D&O
Corporate governance insurance is not a single named policy in the London market but a portfolio of covers designed to protect the company and its individual officers from the financial consequences of alleged governance failure. The core component is directors’ and officers’ liability insurance, which indemnifies natural-person directors and senior managers for defence costs, damages and certain regulatory penalties arising from wrongful acts in their capacity as officers of the company.
Around that core, brokers structure cover to address the specific governance obligations imposed on UK boards: disclosure under the FCA Listing Rules and Disclosure Guidance and Transparency Rules (DTR), the “comply or explain” obligations of the UK Corporate Governance Code, the directors’ duties codified in sections 170 to 177 of the Companies Act 2006, and the conduct standards of the Senior Managers and Certification Regime (SMCR).
The substantive duties insured against derive from several sources. The Companies Act 2006 codifies directors’ general duties — most importantly the section 172 duty to promote the success of the company for the benefit of members, the section 174 duty of reasonable care, skill and diligence, and the section 175 duty to avoid conflicts of interest. The common-law standard of care was restated in Re D’Jan of London Ltd [1994] 1 BCLC 561.
For premium-listed companies, the UK Corporate Governance Code (current edition January 2024, applying to financial years beginning on or after 1 January 2025, with Provision 29 on internal controls effective 1 January 2026) operates on a “comply or explain” basis. DTR 7.2 requires a corporate governance statement in the annual report. Beyond listed companies, the Wates Principles apply to large private companies. For regulated firms, SMCR (extended to all FSMA-authorised firms on 9 December 2019) imposes individual accountability on senior managers, enforceable through FCA powers under FSMA 2000 sections 165 to 168 and the Decision Procedure and Penalties Manual (DEPP).
Civil liability typically arises through derivative actions under section 260 of the Companies Act 2006, shareholder claims under sections 90 and 90A of FSMA 2000 (misstatements in listing particulars and periodic disclosures), and creditor claims following insolvency under the Insolvency Act 1986.
A standard UK D&O wording responds on three “sides”. Side A covers individual directors and officers for loss not indemnified by the company, including in insolvency or where indemnification is legally prohibited. Side B reimburses the company for amounts it has lawfully indemnified to officers. Side C extends to the entity itself for securities claims (typically limited to listed entities or those with traded debt).
Corporate governance-focused enhancements include pre-claim inquiry costs (covering attendance at regulatory interviews before any formal allegation), investigations costs sub-limits (responding to internal investigations triggered by whistleblowing or audit findings), reputational rehabilitation costs paid to approved PR consultants, and extradition costs cover. Some markets offer specific endorsements for breaches of the Corporate Governance Code’s “comply or explain” obligations and for ESG-related disclosure failures. Insurers exclude deliberate dishonesty, personal profit and fraud — but typically only following final adjudication, allowing defence costs to flow in the interim.
The UK D&O market is concentrated in Lloyd’s and the London company market, with AIG, Chubb, Allianz Global Corporate & Specialty, Beazley, Travelers, CFC, Tokio Marine HCC and QBE among the principal participants. Following a hard market from 2018 to 2022, capacity rebounded materially during 2023 and 2024, with rates softening for most risks except those with active securities litigation, ESG controversy or SMCR enforcement exposure. Marsh, Aon, WTW, Howden and Lockton dominate the broking side of the market for larger placements.
Boards should treat governance insurance as part of a wider risk-management framework rather than a substitute for governance itself. Underwriters assess board composition, audit committee effectiveness, internal controls (especially in light of Provision 29 of the 2024 Code), whistleblowing arrangements and prior regulatory history. A clean SMCR record and demonstrable board oversight of ESG and cyber matters typically reduces both premium and excess.
A premium-listed UK mid-cap retailer issued a profit warning following inventory misstatement. The FCA opened an investigation under FSMA 2000 section 168, and a group of institutional shareholders intimated a claim under FSMA 2000 section 90A. The chair and chief executive received Compelled Interview notices. The D&O policy responded by funding individual defence costs under Side A, entity defence costs for the FCA investigation under the investigations sub-limit, and securities defence costs at the entity level under Side C — with crisis communications consultants engaged under the reputational rehabilitation extension.
This entry is part of the Apex Insurance Wiki. Last reviewed by Matt Bartlett on 2026-06-10. Next review: 2026-12-10.
Apex Insurance Brokers Limited. Authorised and regulated by the Financial Conduct Authority, FRN 724952. Registered in England and Wales, Companies House 07014570. This entry provides general information about UK insurance concepts and is not regulated advice. Consult your insurance broker on your specific position.
Apex Insurance Brokers serves UK professional services firms and commercial businesses. Call 0117 325 0027, email hello@apexinsurancebrokers.co.uk, or request a quotation.
Get a quote